Phase 3 2 trials · 1 missed
Phase 3
NCT04704869 Jan 2017 → Dec 2021 —
Bryan Cotton
Completed
Missed primary
Phase 3
NCT00916656 Oct 2009 → Mar 2014 congenital afibrinogenemia CSL Behring
Withdrawn
No outcome recorded
Comparator or background therapy 10 trials
Phase 2
NCT03508141 Comparator Jul 2018 → Jun 2021 blood coagulation disease , hemorrhagic disease Gold Coast Hospital and Health Service
Unknown
No outcome recorded
Phase 2
NCT01187225 Comparator Aug 2010 → Jan 2011 blood coagulation disease University of Sao Paulo
Completed
No outcome recorded
Phase 3
NCT06617897 Comparator Oct 2024 → Sep 2027 expected acquired coagulation factor deficiency CSL Behring
Recruiting
No outcome recorded
Phase 3
NCT05638581 Comparator Jul 2023 → Aug 2026 —
University of Alabama at Birmingham
Completed
No outcome recorded
Phase 3
NCT03932240 Comparator Aug 2019 → Apr 2021 vascular hemostatic disease Emory University
Completed
No outcome recorded
Phase 3
NCT03444324 Comparator Apr 2018 → Sep 2023 coagulation protein disease Biotest
Completed
Met primary
Phase 3
NCT03037424 Comparator Feb 2017 → Nov 2018 acquired coagulation factor deficiency University Health Network, Toronto
Completed
No outcome recorded
Phase 4
NCT04376762 Comparator Oct 2021 → Mar 2023 hemorrhagic disease , juvenile Huntington disease University of Virginia
Completed
No outcome recorded
Phase 4
NCT03045068 Background Apr 2017 → Oct 2018 cardiac rhythm disease , cardiac valvular defect The University of Texas Health Science Center, Houston
Completed
No outcome recorded
Phase 4
NCT03014700 Comparator Mar 2016 → Apr 2018 congenital heart disease Stanford University
Completed
No outcome recorded
Show 5 more trials